Страна: Великобритания
Язык: английский
Источник: MHRA (Medicines & Healthcare Products Regulatory Agency)
Clomethiazole
Neon Healthcare Ltd
N05CM02
Clomethiazole
192mg
Oral capsule
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 04010100; GTIN: 4260095682246
KOEPCKE.PUBLISHING stand (datum): 17.06.2021 [08:00 uhr] (1) format: 420 x 120 mm farben: 1/1-farbig schwarz mat.-nr.: 9000528/19 intrapharm schriftgröße: 9 pt PACKAGE LEAFLET: INFORMATION FOR THE USER CLOMETHIAZOLE 192 MG CAPSULES CLOMETHIAZOLE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Clomethiazole Capsules are and what they are used for 2. What you need to know before you take Clomethiazole Capsules 3. How to take Clomethiazole Capsules 4. Possible side effects 5. How to store Clomethiazole Capsules 6. Contents of the pack and other information 1. WHAT CLOMETHIAZOLE CAPSULES ARE AND WHAT THEY ARE USED FOR Clomethiazole Capsules contain a medicine called clomethiazole. This belongs to a group of medicines called hypnotics and sedatives. It has a calming (sedative) effect on your nervous system. Clomethiazole Capsules are used to: • Treat feelings of restlessness and agitation. • Help you if you are unable to sleep (short-term treatment). • Relieve the symptoms of alcohol withdrawal. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CLOMETHIAZOLE CAPSULES DO NOT TAKE CLOMETHIAZOLE CAPSULES: • if you are allergic to clomethiazole or any of the other ingredients of this medicine (listed in section 6). • if you have lung or breathing problems which have recently got worse. Do not take Clomethiazole Capsules if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Clomethiazole Capsules. WARNING AND PRECAUTIONS Talk to your doctor or ph Прочитать полный документ
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Heminevrin 192 mg Capsules Clomethiazole 192 mg Capsules 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Clomethiazole 192 mg (base) per capsule. Excipients with known effect: 7 mg Sorbitol (E420) per capsule. For a full list of excipients, see 6.1. 3 PHARMACEUTICAL FORM Soft Capsules Greyish-brown, soft gelatin capsules 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Clomethiazole is a short acting hypnotic and sedative with anticonvulsant effect. It is used for the: management of restlessness and agitation in the elderly, short term treatment of severe insomnia in the elderly and treatment of alcohol withdrawal symptoms where close hospital supervision is also provided. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Management of restlessness and agitation in the elderly: one capsule three times daily. Severe insomnia in the elderly: 1 - 2 capsules before going to bed. The lower dose should be tried first. As with all psychotropic drugs, treatment should be kept to a minimum, reviewed regularly and discontinued as soon as possible. Alcohol withdrawal states: Clomethiazole is not a specific 'cure' for alcoholism. Alcohol withdrawal should be treated in hospital or, in exceptional circumstances, on an outpatient basis by specialist units when the daily dosage of clomethiazole must be monitored closely by community health staff. The dosage should be adjusted to patient response. The patient should be sedated but rousable. A suggested regimen is: Initial dose: 2 to 4 capsules, if necessary repeated after some hours. Day 1, first 24 hours: 9 to 12 capsules, divided into 3 or 4 doses. Day 2: 6 to 8 capsules, divided into 3 or 4 doses. Day 3: 4 to 6 capsules, divided into 3or 4 doses. Days 4 to 6: A gradual reduction in dosage until the final dose. Administration for more than nine (9) days is not recommended. _Paediatric population _ The safety and efficacy of Clomethiazole in children and adolescents under 18 years of age has not been established. Прочитать полный документ